Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
cancer immunotherapy
2
×
deals
genentech
2
×
life sciences
national blog main
national top stories
new york blog main
roche
2
×
san francisco blog main
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
apalutamide
atypical hemolytic uremic syndrome
bill cassidy
biogen
boston
boulder/denver blog main
boulder/denver top stories
caelum biosciences
celgene
center for medicare and medicaid services
chuck grassley
companion diagnostic
corvus pharmaceuticals
crenezumab
daniel o'day
dengue fever
department of health and human services
detroit blog main
What
acquire
agreed
alzheimer’s
big
billion
bio
broad
companies
confidence
didn’t
different
drug
fail
foundation
gain
gene
genentech
increases
latest
medicine
momentum
morning
panels
pay
pays
pharmaceutical
picked
plan
prescription
price
prices
profiling
raise
recently
redux
remaining
rest
roche
roundup
share
Language
Current search:
genentech
×
roche
×
" cancer immunotherapy "
×
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
